BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-07-22

Reporting Person: LAWLIS V BRYAN (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-22	Common Stock	M	6400	$17.33	Acquired	20260	Direct
2016-07-22	Common Stock	S	6400	$95.01	Disposed	13860	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-22	Stock Option (Right to buy) Common Stock	$17.33	M	6400	Disposed	2017-06-06	Common Stock (6400)	Direct

F1: Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016.

F2: All shares were sold at the same price.

F3: Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter

F4: Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction.